Page 147 - Orange Book Cumulative Supplement 10 October 2012

A - 10
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content

PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
DEXAMETHASONE - OZURDEX
N022315 001 8088407 Oct 20, 2020 DP U-1205
DEXAMETHASONE; TOBRAMYCIN - TOBRADEX ST
N050818 001 8101582 Dec 19, 2027 DP U-1082
DEXLANSOPRAZOLE - DEXILANT
N022287 001 8105626 Sep 27, 2026 DP
8105626*PED Mar 27, 2027
8173158 Mar 17, 2030 U-951
8173158 Mar 17, 2030 U-950
8173158 Mar 17, 2030 U-949
8173158*PED Sep 17, 2030
DEXLANSOPRAZOLE - DEXILANT
N022287 002 8105626 Sep 27, 2026 DP
8105626*PED Mar 27, 2027
8173158 Mar 17, 2030 U-951
8173158 Mar 17, 2030 U-950
8173158 Mar 17, 2030 U-949
8173158*PED Sep 17, 2030
DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE - NUEDEXTA
N021879 001 8227484 Jul 17, 2023 U-1093

DICLOFENAC POTASSIUM - CAMBIA
N022165 001 8097651 Jun 16, 2026 DS DP U-436
DICLOFENAC POTASSIUM - ZIPSOR
N022202 001 8110606 Feb 24, 2029 U-980
DICLOFENAC SODIUM - PENNSAID
N020947 001 8217078 Jul 10, 2029 U-1248
DIENOGEST; ESTRADIOL VALERATE - NATAZIA
N022252 001 8153616 Jan 30, 2028 U-1240 I-648 Mar 14, 2015

DIFLUPREDNATE - DUREZOL
N022212 001 I-653 Jun 13, 2015
ODE Jun 13, 2019
DIPHENHYDRAMINE CITRATE; IBUPROFEN - ADVIL PM
N021394 001 8263647 May 30, 2022 DP
DORIPENEM - DORIBAX
N022106 001 8247402 Mar 30, 2021 DS DP
DORIPENEM - DORIBAX
N022106 002 8247402 Mar 30, 2021 DS DP

DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE - COSOPT PF
N202667 001 NP Feb 01, 2015
DOXYCYCLINE - ORACEA
N050805 001 8206740 Dec 24, 2025 DP U-925
DRONEDARONE HYDROCHLORIDE - MULTAQ
N022425 001 5223510 Jul 26, 2013 DS DP U-992
5223510 Jul 26, 2013 DS DP U-1261